Organophosphorus flame retardants inhibit specific liver carboxylesterases and cause serum hypertriglyceridemia

ACS Chemical Biology

Volumn 9, Issue 5, 2014, Pages 1097-1103

  Morris, Patrick J ^a   Medina Cleghorn, Daniel ^a   Heslin, Ann ^a   King, Sarah M ^b   Orr, Joseph ^b   Mulvihill, Melinda M ^a   Krauss, Ronald M ^b   Nomura, Daniel K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYLESTERASE; FLAME RETARDANT; LIPID; ORGANOPHOSPHORUS FLAME RETARDANT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ORGANOPHOSPHORUS COMPOUND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; HYPERTRIGLYCERIDEMIA; LIPID LIVER LEVEL; LIPID METABOLISM; METABOLOMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHEMICALLY INDUCED; DRUG EFFECTS; ENZYMOLOGY; HEK293 CELL LINE; LIVER; METABOLISM;

ANIMALS; CARBOXYLIC ESTER HYDROLASES; FLAME RETARDANTS; HEK293 CELLS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIVER; MICE; ORGANOPHOSPHORUS COMPOUNDS;

EID: 84900841051     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb500014r     Document Type: Article

References (30)

1. van der Veen, I. and de Boer, J. (2012) Phosphorus flame retardants: Properties, production, environmental occurrence, toxicity, and analysis Chemosphere 88, 1119-1153
2. Van den Eede, N., Neels, H., Jorens, P. G., and Covaci, A. (2013) Analysis of organophosphate flame retardant diester metabolites in human urine by liquid chromatography electrospray ionisation tandem mass spectrometry J. Chromatogr. A 1303, 48-53
3. Meeker, J. D. and Stapleton, H. M. (2010) House dust concentrations of organophosphate flame retardants in relation to hormone levels and semen quality parameters Environ. Health Perspect. 118, 318-323
4. Tornoe, C. W., Christensen, C., and Meldal, M. (2002) Peptidotriazoles on solid phase: [1,2,3]-Triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides J. Org. Chem. 67, 3057-3064
5. Rostovtsev, V. V., Green, L. G., Fokin, V. V., and Sharpless, K. B. (2002) A stepwise huisgen cycloaddition process: Copper(I)-catalyzed regioselective ligation of azides and terminal alkynes Angew. Chem. 41, 2596-2599
6. Schirmer, E. C., Yates, J. R., 3rd, and Gerace, L. (2003) MudPIT: A powerful proteomics tool for discovery Discovery Med. 3, 38-39
7. Holmes, R. S., Wright, M. W., Laulederkind, S. J., Cox, L. A., Hosokawa, M., Imai, T., Ishibashi, S., Lehner, R., Miyazaki, M., Perkins, E. J., Potter, P. M., Redinbo, M. R., Robert, J., Satoh, T., Yamashita, T., Yan, B., Yokoi, T., Zechner, R., and Maltais, L. J. (2010) Recommended nomenclature for five mammalian carboxylesterase gene families: Human, mouse, and rat genes and proteins Mamm. Genome 21, 427-441
8. Long, J. Z. and Cravatt, B. F. (2011) The metabolic serine hydrolases and their functions in mammalian physiology and disease Chem. Rev. 111, 6022-6063
9. Medina-Cleghorn, D. and Nomura, D. K. (2013) Chemical approaches to study metabolic networks Pflugers Archiv. 465, 427-440
10. Nomura, D. K., Dix, M. M., and Cravatt, B. F. (2010) Activity-based protein profiling for biochemical pathway discovery in cancer Nat. Rev. 10, 630-638
11. Bachovchin, D. A. and Cravatt, B. F. (2012) The pharmacological landscape and therapeutic potential of serine hydrolases Nat. Rev. 11, 52-68
12. Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K.-L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., OBrien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E. (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes Nat. Chem. Biol. 10, 113-121
13. Evans, M. J. and Cravatt, B. F. (2006) Mechanism-based profiling of enzyme families Chem. Rev. 106, 3279-3301
14. Kidd, D., Liu, Y., and Cravatt, B. F. (2001) Profiling serine hydrolase activities in complex proteomes Biochemistry 40, 4005-4015
15. Liu, Y., Patricelli, M. P., and Cravatt, B. F. (1999) Activity-based protein profiling: The serine hydrolases Proc. Natl. Acad. Sci. U.S.A. 96, 14694-14699
16. Medina-Cleghorn, D., Heslin, A., Morris, P. J., Mulvihill, M. M., and Nomura, D. K. (2014) Multidimensional profiling platforms reveal metabolic dysregulation caused by organophosphorus pesticides ACS Chem. Biol. 9, 423-432
17. Nomura, D. K. and Casida, J. E. (2011) Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain J. Agric. Food Chem. 59, 2808-2815
18. Kovarik, Z., Radic, Z., Berman, H. A., Simeon-Rudolf, V., Reiner, E., and Taylor, P. (2004) Mutant cholinesterases possessing enhanced capacity for reactivation of their phosphonylated conjugates Biochemistry 43, 3222-3229
19. Wang, J., Williams, E. T., Bourgea, J., Wong, Y. N., and Patten, C. J. (2011) Characterization of recombinant human carboxylesterases: Fluorescein diacetate as a probe substrate for human carboxylesterase 2 Drug Metab. Dispos. 39, 1329-1333
20. Imai, T. (2006) Human carboxylesterase isozymes: Catalytic properties and rational drug design Drug Metab. Pharmacokinet. 21, 173-185
21. Quiroga, A. D., Li, L., Trotzmuller, M., Nelson, R., Proctor, S. D., Kofeler, H., and Lehner, R. (2012) Deficiency of carboxylesterase 1/esterase-x results in obesity, hepatic steatosis, and hyperlipidemia Hepatology 56, 2188-2198
22. Wang, H. and Eckel, R. H. (2009) Lipoprotein lipase: From gene to obesity Am. J. Physiol.: Endocrinol. Metab. 297, E271-288
23. Benjamin, D. I., Cozzo, A., Ji, X., Roberts, L. S., Louie, S. M., Mulvihill, M. M., Luo, K., and Nomura, D. K. (2013) Ether lipid generating enzyme AGPS alters the balance of structural and signaling lipids to fuel cancer pathogenicity Proc. Natl. Acad. Sci. U.S.A. 110, 14912-14917
24. Jornayvaz, F. R. and Shulman, G. I. (2012) Diacylglycerol activation of protein kinase Cepsilon and hepatic insulin resistance Cell Metab. 15, 574-584
25. Lian, J. H., Quiroga, A. D., Li, L., and Lehner, R. (2012) Ces3/TGH deficiency improves dyslipidemia and reduces atherosclerosis in Ldlr(/) mice Circ. Res. 111, 982
26. Dominguez, E., Galmozzi, A., Chang, J. W., Hsu, K.-L., Pawlak, J., Li, W., Godio, C., Thomas, J., Partida, D., Niessen, S., O'Brien, P. E., Russell, A. P., Watt, M. J., Nomura, D. K., Cravatt, B. F., and Saez, E. (2014) Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes Nat. Chem. Biol. 10, 113-121
27. Patisaul, H. B., Roberts, S. C., Mabrey, N., McCaffrey, K. A., Gear, R. B., Braun, J., Belcher, S. M., and Stapleton, H. M. (2013) Accumulation and endocrine disrupting effects of the flame retardant mixture Firemaster 550 in rats: An exploratory assessment J. Biochem. Mol. Toxic. 27, 124-136
28. Ko, K. W., Erickson, B., and Lehner, R. (1791) Es-x/Ces1 prevents triacylglycerol accumulation in McArdle-RH7777 hepatocytes Biochim. Biophys. Acta 1133-1143, 2009
29. Elliott, L., Arbes, S. J., Harvey, E. S., Lee, R. C., Salo, P. M., Cohn, R. D., London, S. J., and Zeldin, D. C. (2007) Dust weight and asthma prevalence in the National Survey of Lead and Allergens in Housing (NSLAH) Environ. Health Perspect. 115, 215-220
30. Reemtsma, T., Lingott, J., and Roegler, S. (2011) Determination of 14 monoalkyl phosphates, dialkyl phosphates and dialkyl thiophosphates by LC-MS/MS in human urinary samples Sci. Total Environ. 409, 1990-1993